$0.8207
-0.03-3.45%
At close: -
$0.8207
0.000.00%
After Hours: Jan 31, 4:02 PM EDT
Century Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Century Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-05 | $-0.37 | $-0.45 | 17.8 % |
Q2 | 2024-08-08 | $-0.38 | $-0.46 | 17.4 % |
Q1 | 2024-05-09 | $-0.45 | $-0.50 | 10.0 % |
Q4 | 2024-03-14 | $-0.65 | $-0.55 | -18.2 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-05 | $791.00K | $2.02M | -60.8 % |
Q1 | 2024-05-09 | $855.00K | $1.26M | -32.1 % |
Q4 | 2024-03-14 | $268.00K | $1.84M | -85.4 % |
Q3 | 2023-11-09 | $148.00K | $1.16M | -87.2 % |
Century Therapeutics (IPSC) is scheduled to report earnings on March 13, 2025. The last reported earnings were for reported on November 5, 2024 for Q3.
The Actual EPS was $-0.37, which beat the estimate of $-0.45.
The Actual Revenue was $791K, which missed the estimate of $2M.
Browse earnings estimates, EPS, and revenue on all stocks.